Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MCAC Exec. Cmte. Must Defend Panel Process In Face Of Mounting Criticism

This article was originally published in The Gray Sheet

Executive Summary

Medicare Coverage Advisory Committee medical specialty panels should routinely consider expert opinion related to "clinical evidence" when making recommendations to the Health Care Financing Administration, the American Medical Association recommends in a May 9 letter to the agency.

You may also be interested in...



Inadequate Gender Analysis In NIH-Supported Clinical Research Observed

A Society for Women's Health Research representative is expected to testify that gender analysis in NIH-supported clinical research is inadequate at a Senate HELP/Public Health Subcommittee hearing scheduled for mid-June.

Tunis Takes HCFA/CAG Lead In Midst Of Policy Debate, Possible Restructuring

The use of expert clinical opinion in making Medicare coverage decisions is one of several contentious issues that Sean Tunis, MD, will need to address when he becomes director of the Coverage and Analysis Group at the Health Care Financing Administration in early to mid July.

Inadequate Gender Analysis In NIH-Supported Clinical Research Observed

A Society for Women's Health Research representative is expected to testify that gender analysis in NIH-supported clinical research is inadequate at a Senate HELP/Public Health Subcommittee hearing scheduled for mid-June.

Related Content

UsernamePublicRestriction

Register

MT013410

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel